Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David L Bushnell
Feasibility and Advantage of Adding 131i-Mibg to 90y-Dotatoc for Treatment of Patients With Advanced Stage Neuroendocrine Tumors
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
Related publications
Semi-Automatic 3d-Volumetry of Liver Metastases From Neuroendocrine Tumors to Improve Combination Therapy With 177Lu-Dotatoc and 90y-Dotatoc
Diagnostic and Interventional Radiology
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
Current Treatment Strategies for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Clinical Diabetes and Endocrinology
Endocrinology
Metabolism
Diabetes
Effects and Safety of 131i-Metaiodobenzylguanidine (MIBG) Radiotherapy in Malignant Neuroendocrine Tumors: Results From a Multicenter Observational Registry
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Intraarterial Treatment of GEP NET: 68Ga-Dotatoc SUV Cannot Predict 90y-Dotatoc Uptake
Clinical Cancer Research
Cancer Research
Oncology
Comparative Biodistribution and Radiation Dosimetry of 68Ga-Dotatoc and 68Ga-Dotatate in Patients With Neuroendocrine Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Treatment for Advanced Tumors: SRC Reclaims Center Stage
Clinical Cancer Research
Cancer Research
Oncology
68 Ga-Dotatoc Imaging of Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors
Oncologist
Cancer Research
Medicine
Oncology
